ROCHE : receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy
MarketScreener,
About 90,000 women globally die from endometrial cancer each year 1 VENTANA MMR RxDx Panel is the first immunohistochemistry…